Arkolith/Insider Trading/JNCE/Form 4

Cole Hugh M

Chief Operating OfficerJounce Therapeutics, Inc. (JNCE) · full profile →Form 4 · filed Jan 11, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$18K
Net Open-Market Flow
-$18K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 10, 2023Sell(S)9K$1.12$10K110K
Jan 9, 2023Sell(S)7K$1.10$8K119K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001640455-23-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML